Older patients and those with diminished ovarian reserve can have a poor response to fertility treatments. Many of these patients mistakenly believe that donor eggs are the only option for pregnancy....
(PRWeb December 18, 2012)
Read the full story at http://www.prweb.com/releases/ivfplano/12/prweb10228871.htm
Dallas-Fort Worth Fertility Associates announces one of North Texas’ first live births with blastocyst embryo biopsy, an emerging technology used to screen embryos for chromosomal abnormalities before...
(PRWeb December 18, 2012)
Read the full story at http://www.prweb.com/releases/DFA/2012/prweb10229756.htm
Medzilla Reports: In November the nation saw an important drop in the country's unemployment rate, signaling the continued steady improvement of the overall economic situation (bls.gov,...
(PRWeb December 18, 2012)
Read the full story at http://www.prweb.com/releases/2012/12/prweb10247748.htm
Authority in Regenerative Medicine, Cell Therapy and Stem Cell Research and Development Joins Provia Labs’ Scientific Advisory Team.
(PRWeb December 18, 2012)
Read the full story at http://www.prweb.com/releases/JoeLaningPhDJoinsProvia/12_18_2012/prweb10249645.htm
Ramey & Browning, PLLC has new offices and has hired Harry Laxton Jr. as of counsel to meet growing client needs.
(PRWeb December 18, 2012)
Read the full story at http://www.prweb.com/releases/Ramey/Browning/prweb10247807.htm
Yali Friedman lives in Washington, DC and is author of Building Biotechnology and other books; founder of DrugPatentWatch; and chief editor of the Journal of Commercial Biotechnology.
Recent Comments